摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-溴-7-甲基苯并[1,2,5]噻二唑 | 2255-80-3

中文名称
4-溴-7-甲基苯并[1,2,5]噻二唑
中文别名
4-溴-7-甲基苯并[C][1,2,5]噻二唑
英文名称
4-bromo-7-methyl-2,1,3-benzothiadiazole
英文别名
4-bromo-7-methylbenzo[c][1,2,5]thiadiazole;4-bromo-7-methylbenzo-2,1,3-thiadiazole;7-bromo-4-methyl-2,1,3-benzothiadiazole;4-methyl-7-bromo-2,1,3-benzothiadiazole
4-溴-7-甲基苯并[1,2,5]噻二唑化学式
CAS
2255-80-3
化学式
C7H5BrN2S
mdl
——
分子量
229.1
InChiKey
MZFRKYXVQYNOFA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    139.3-140.3 °C
  • 沸点:
    292.7±20.0 °C(Predicted)
  • 密度:
    1.736±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    54
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2934999090
  • 危险性防范说明:
    P261,P280,P301+P312,P302+P352,P305+P351+P338
  • 危险性描述:
    H302,H315,H320,H335

SDS

SDS:033996c7cb693f707b2b1fc4730aaea8
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Bromo-7-methyl-benzo[1,2,5]thiadiazole
4-Bromo-7-methyl-2lamda{4},1,3-benzothiadiazole
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-Bromo-7-methyl-benzo[1,2,5]thiadiazole
CAS number: 2255-80-3

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H5BrN2S
Molecular weight: 229.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide, sulfur oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 一种含有苯并[c][1,2,5]噻二唑衍生物受体结构单元的有机发光材料及应用
    申请人:浙江工业大学
    公开号:CN111471043B
    公开(公告)日:2022-07-26
    本发明提供的一种基于苯并[c][1,2,5]噻二唑‑4‑醛基受体和2‑(苯并[c][1,2,5]噻二唑‑4‑亚甲基)丙二腈受体的给体‑受体结构的有机发光材料及其应用。所述有机发光材料为受体‑给体分离的体系,其中受体为苯并[c][1,2,5]噻二唑‑4‑醛基或2‑(苯并[c][1,2,5]噻二唑‑4‑亚甲基)丙二腈,给体为咔唑及衍生物或苯噁嗪等。该材料中最低未占有轨道(LUMO)均处于受体,最高占有轨道(HOMO)均处于给体中,因此,通过受体结构及给体的电性调节可对发光材料的分子轨道能级进行有效调控。通过调控发光材料的结构或给体的供电子能力,可方便的调节材料分子的发光颜色。本发明的有机发光材料具有发光颜色易调的特点,可作为发光材料用于OLED器件中的制备。
  • 光电转换材料以及光电转换元件
    申请人:松下知识产权经营株式会社
    公开号:CN109384801B
    公开(公告)日:2022-08-09
    本申请的光电转换材料包含下述式(1)所示的化合物。式中,X选自氢原子、重氢原子、卤原子、烷基和氰基,Y为下述式(2)所示的一价取代体,式中,R1~R10各自独立地为氢原子、重氢原子、卤原子、烷基或芳基,或者选自R1~R10中的两个以上相互键合而形成环,剩余各自独立地为氢原子、重氢原子、卤原子、烷基或芳基,*表示上述式(1)中的Y的键合位置,Ar1选自下述多个式(3)所示的多个结构。式中,**表示上述式(2)中的Ar1与N的键合位置。
  • A Rhodanine Flanked Nonfullerene Acceptor for Solution-Processed Organic Photovoltaics
    作者:Sarah Holliday、Raja Shahid Ashraf、Christian B. Nielsen、Mindaugas Kirkus、Jason A. Röhr、Ching-Hong Tan、Elisa Collado-Fregoso、Astrid-Caroline Knall、James R. Durrant、Jenny Nelson、Iain McCulloch
    DOI:10.1021/ja5110602
    日期:2015.1.21
    generation and efficient photocurrent generation from both donor and acceptor. Ultrafast transient absorption spectroscopy was used to investigate polaron generation efficiency as well as recombination dynamics. It was determined that the P3HT:FBR blend is highly intermixed, leading to increased charge generation relative to comparative devices with P3HT:PC60BM, but also faster recombination due to a
    合成了一种带有 3-乙基罗丹宁侧翼基团的新型小分子 FBR 作为非富勒烯电子受体,用于溶液处理的本体异质结有机光伏 (OPV)。采用了一种简单的合成路线,为大规模制备这种材料提供了潜力。采用聚(3-己基噻吩)(P3HT)作为供体聚合物和 FBR 作为受体的倒置 OPV 器件的功率转换效率(PCE)高达 4.1%。瞬态和稳态光谱表明供体和受体均产生高效、超快的电荷和光电流。超快瞬态吸收光谱用于研究极化子产生效率以及复合动力学。确定 P3HT:FBR 混合物高度混合,导致相对于具有 P3HT:PC60BM 的比较器件产生更多的电荷,但由于非理想的形态,也导致更快的重组,与 P3HT:PC60BM 器件相比,受体不会聚集到足以产生适当的渗透途径,从而阻止快速的非偶合重组. 尽管存在这种非最佳形态,P3HT:FBR 器件表现出比 P3HT:PC60BM 器件更好的性能,用作对照,表明该受体显示出进一步优化的巨大希望。
  • [EN] COMPOUNDS FOR INHIBITION OF ALPHA 4β7 INTEGRIN<br/>[FR] COMPOSÉS POUR INHIBITION DE L'INTÉGRINE ALPHA 4β7
    申请人:GILEAD SCIENCES INC
    公开号:WO2020092401A1
    公开(公告)日:2020-05-07
    The present disclosure provides a compound of Formula (I); or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.
    本公开提供一种如下所述的化合物的化学式(I);或其药用可接受的盐。本公开还提供包括化合物的药物组合物的制备方法,制备化合物的方法和治疗炎症性疾病的治疗方法。
  • Synthesis of 2,1,3-benzothiadiazolecarbonitriles
    作者:K. Pilgram、R. D. Skiles
    DOI:10.1002/jhet.5570110521
    日期:1974.10
    les, 2, have been prepared by two different methods. Reaction of bromo-2,1,3-benzothiadiazoles, 1, with cuprous cyanide occurs advantageously in refluxing dimethylformamide to give 2, complexed with curpous bromide. Hydrogen peroxide in hydrochloric acid at 30–40° is shown to be an effective reagent for efficient decomposition of these reactions complexes, 2 CuBr, and subsequent isolation of 2. Yields
    2,1,3-Benzothiadiazolecarbonitriles,2,制备由两种不同的方法。溴-2,1,3-苯并噻二唑1与氰化亚铜的反应有利地发生在回流的二甲基甲酰胺中,生成2与溴化氯络合的化合物。在30-40在盐酸过氧化氢被示°是用于这些反应的复合物的高效分解,有效试剂2 CuBr和随后分离2.在桑德迈尔方法产生用于制备腈2通过重氮化氨基-2-得到改善在与亚铜氰化钠络合物反应之前,先用亚硝酰基-硫酸将1,,3-苯并噻二唑3。
查看更多

同类化合物

(5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 阿拉酸式苯-S-甲基 阿拉酸式苯 试剂4,7-Bis(5-bromo-2-thienyl)-5,6-bis(dodecyloxy)-2,1,3-benzothiadiazole 苯并恶唑-6-胺 苯并[d][1,2,3]噻二唑-6-羧酸 苯并[C][1,2,5]噻二唑-5-硼酸频那醇酯 苯并[C][1,2,5]噻二唑-4-磺酸钠 苯并[C][1,2,5]噻二唑-4-基甲醇 苯并[C][1,2,5]噻二唑-4,7-二基二硼酸 苯并[1,2,5]噻二唑-4-羧酸 苯并[1,2,5]噻二唑-4-磺酰氯 苯并[1,2,3]噻二唑-7-基胺 苯并[1,2,3]噻二唑-6-羧酸甲酯 苯并[1,2,3]噻二唑-5-基胺 苯并[1,2,3]噻二唑-4-基胺 苯2,1,3-噻重氮-5-羧酸酯 碘化(2,1,3-苯并硫杂(SIV)二唑-5-基)二甲基八氧代甲基铵 硫代磷酸S-[(2,1,3-苯并噻二唑-5-基)甲基]酯O,O-二钠盐 盐酸替扎尼定-d4 盐酸替扎尼定 灭草荒 替托尼定D4 替扎尼定杂质1 替扎尼定 噻唑并[4,5-f]-2,1,3-苯并噻二唑,6-甲基-(6CI,8CI) 去氢替扎尼定 全氟苯并[c][1,2,5]噻二唑 [7-[2-[2-(8-硫杂-7,9-二氮杂双环[4.3.0]壬-3,5,9-三烯-7-基)乙基二巯基]乙基]-8-硫杂-7,9-二氮杂双环[4.3.0]壬-3,5,9-三烯-2-基]甲胺 N-甲氧基-N-甲基-2,1,3-苯并噻二唑-5-酰胺 N-(5-氯-2,1,3-苯并噻二唑-4-基)硫脲 N,N'-二硫代二(亚乙基)二(2,1,3-苯并噻二唑-5-甲胺) N'-2,1,3-苯并噻二唑-4-基-N,N-二甲基酰亚胺基甲酰胺 BTQBT(升华提纯) 7H-咪唑并[4,5-g][1,2,3]苯并噻二唑 7H-咪唑并[4,5-e][1,2,3]苯并噻二唑 7-肼基[1,3]噻唑并[4,5-e][2,1,3]苯并噻二唑 7-硝基-苯并[1,2,5]噻二唑-4-基胺 7-硝基-1,2,3-苯并噻二唑 7-甲基[1,3]噻唑并[5,4-e][2,1,3]苯并噻二唑 7-甲基[1,3]噻唑并[4,5-e][2,1,3]苯并噻二唑 7-甲基[1,3]噻唑并[4,5-e][1,2,3]苯并噻二唑 7-溴苯并[c][1,2,5]噻二唑-4-磺酸 7-溴-苯并[D][1,2,3]噻二唑 7-溴-5-甲基-4-硝基-2,1,3-苯并噻二唑 7-溴-4-醛基苯并[C][1,2,5]噻二唑 7-溴-2,1,3-苯并噻二唑-4-磺酰氯 7-溴-2,1,3-苯并噻二唑-4-甲腈 7-溴-2,1,3-苯并噻二唑-4-亚磺酸 7-氯-苯并[1,2,5]噻二唑-4-基胺